Menstrual cycle phase and therapeutic response to neuroleptic treatment in female patients with schizophrenia;Fáze menstruačního cyklu a terapeutická odezva na neuroleptickou léčbu u pacientek schizofreniček

Casopis Lekaru Ceskych

Volumn 140, Issue 21, 2001, Pages 668-670

  Vanurova I ^a   Yamamotova A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Estrogen; Menstrual cycle; Schizophrenia

Indexed keywords

ESTROGEN; NEUROLEPTIC AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN BLOOD LEVEL; FEMALE; HOSPITALIZATION; HUMAN; MENSTRUAL CYCLE; PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME; ADULT; BLOOD;

ADULT; ANTIPSYCHOTIC AGENTS; ENGLISH ABSTRACT; ESTROGENS; FEMALE; HUMAN; MENSTRUAL CYCLE; SCHIZOPHRENIA;

EID: 0035155276     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gender differences in schizophrenia: Rehospitalization and community survival
2. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia
3. Psychosis and pregnancy
4. Factors related to tardive dyskinesia
5. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia
6. Gender and expression of schizophrenia
7. Prolactin and neuroleptic drugs
8. An animal model for the effects of estradiol on dopamine-mediated behavior: Implication for sex differences in schizophrenia
9. Variation in symptom severity over the menstrual cycle in schizophrenics
10. Estrogen levels relate to neuropsychological function in female schizophrenics
11. Epidemiology of puerperal psychoses
12. A clinical trial of the effects of estrogen in acutely psychotic women
13. Acute psychiatric admission related to the menstrual cycle
14. Auditory hallucination in women and men
15. Interaction of sex, age and neuroleptic dose
16. The role of estrogen in schizophrenia